83
58
Growth Score
-5 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
434799
Biocrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation.
- David Brooks: CEOPast Role: Ablatus Therapeutics, CEO
- Niall Armes: Chief Scientific OfficerPast Role: TwistDx, Founder and CEO
About the Company
Biocrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation.
